Author Search Results :: UTM Library Massive Scholar Tracking

1

A case of benign immunoglobulin D monoclonal gammopathy of undetermined significance with 26 years of follow‐up by Larry D. Anderson Jr., Joan Bladé, Robert A. Kyle

Published 2024-02-01

Get full text

Article

2

Editorial: T-cell directed therapies in multiple myeloma by Joshua Richter, Larry D. Anderson, Karthik Ramasamy, Karthik Ramasamy, Adriana Rossi

Published 2023-06-01

Get full text

Article

3

Once-weekly bortezomib as the standard of care in multiple myeloma: results from an international survey of physicians by Rahul Banerjee, Bo Wang, Larry D. Anderson, Georgia McCaughan, Nikita Mehra, Andrew J. Cowan, S. Vincent Rajkumar, Gurbakhash Kaur

Published 2023-11-01

Get full text

Article

4

$Non-myeloablative allogeneic hematopoietic cell transplantation for relapsed or refractory Waldenström macroglobulinemia: evidence for a graft-versus-lymphoma effect$

Non-myeloablative allogeneic hematopoietic cell transplantation for relapsed or refractory Waldenström macroglobulinemia: evidence for a graft-versus-lymphoma effect by Enrico Maffini, Larry D. Anderson, Brenda M. Sandmaier, Damian J. Green, Barry E. Storer, Dietger Niederwieser, Richard T. Maziarz, David G. Maloney, Rainer Storb

Published 2018-06-01

Get full text

Article

5

Cardiovascular disease and chimeric antigen receptor cellular therapy by Anjali Rao, Anjali Rao, Anjali Rao, Andrew Stewart, Andrew Stewart, Mahmoud Eljalby, Mahmoud Eljalby, Praveen Ramakrishnan, Larry D. Anderson, Larry D. Anderson, Farrukh T. Awan, Alvin Chandra, Alvin Chandra, Alvin Chandra, Srilakshmi Vallabhaneni, Srilakshmi Vallabhaneni, Srilakshmi Vallabhaneni, Kathleen Zhang, Kathleen Zhang, Kathleen Zhang, Vlad G. Zaha, Vlad G. Zaha, Vlad G. Zaha

Published 2022-09-01

Get full text

Article

6

Once-weekly versus twice-weekly bortezomib in newly diagnosed multiple myeloma: a real-world analysis by Fieke W. Hoff, Rahul Banerjee, Adeel M. Khan, Georgia McCaughan, Bo Wang, Xiaoliang Wang, James Roose, Larry D. Anderson, Andrew J. Cowan, S. Vincent Rajkumar, Gurbakhash Kaur

Published 2024-03-01

Get full text

Article

7

Patient perspectives on BCMA-targeted therapies for multiple myeloma: a survey conducted in a patient advocacy group by Jay R. Hydren, Dee Lin, Nathan W. Sweeney, Bingcao Wu, Nina Kim, Saurabh Patel, Douglas W. Sborov, Jesus G. Berdeja, Larry D. Anderson, Stephen Huo, Jorge Arturo Hurtado Martínez, Jennifer M. Ahlstrom

Published 2024-04-01

Get full text

Article

8

P932: PATIENT PERSPECTIVES ON BCMA-TARGETED THERAPIES FOR MULTIPLE MYELOMA: A SURVEY CONDUCTED IN A PATIENT ADVOCACY GROUP by Jay R. Hydren, Dee Lin, Jorge Arturo Hurtado, Nathan W. Sweeney, Bingcao Wu, Katharine Gries, Nina Kim, Saurabh Patel, Douglas W. Sborov, Jesus Berdeja, Larry D. Anderson, Jinhai Stephen Huo, Jennifer M. Ahlstrom

Published 2023-08-01

Get full text

Article

9

S193: BMS-986393 (CC-95266), A G PROTEIN–COUPLED RECEPTOR CLASS C GROUP 5 MEMBER D (GPRC5D)–TARGETED CAR T-CELL THERAPY FOR RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): RESULTS FRO... by Susan Bal, Jesus Berdeja, Myo Htut, Mehmet Kocoglu, Tara Gregory, Larry D. Anderson, Adriana Rossi, Daniel Egan, Luciano Costa, Lisa Kelly, Safiyyah Ziyad, Hongxiang Hu, Yanping Chen, Allison J. Kaeding, Michael Burgess, Kristen Hege, Omar Nadeem

Published 2023-08-01

Get full text

Article

10

$KarMMa-RW: comparison of idecabtagene vicleucel with real-world outcomes in relapsed and refractory multiple myeloma$

KarMMa-RW: comparison of idecabtagene vicleucel with real-world outcomes in relapsed and refractory multiple myeloma by Sundar Jagannath, Yi Lin, Hartmut Goldschmidt, Donna Reece, Ajay Nooka, Alicia Senin, Paula Rodriguez-Otero, Ray Powles, Kosei Matsue, Nina Shah, Larry D. Anderson, Matthew Streetly, Kimberly Wilson, Hoa Van Le, Arlene S. Swern, Amit Agarwal, David S. Siegel

Published 2021-06-01

Get full text

Article

11

Transferring care to enhance access to early-phase cancer clinical trials: Protocol to evaluate a novel program by Chika Nwachukwu, Sukh Makhnoon, Marieshia Person, Meera Muthukrishnan, Syed Kazmi, Larry D. Anderson, Jr, Gurbakhash Kaur, Kandice A. Kapinos, Erin L. Williams, Oluwatomilade Fatunde, Navid Sadeghi, Fabian Robles, Alice Basey, Thomas Hulsey, Sandi L. Pruitt, David E. Gerber

Published 2024-06-01

Get full text

Article

12

Daratumumab plus lenalidomide/bortezomib/dexamethasone in Black patients with transplant-eligible newly diagnosed multiple myeloma in GRIFFIN by Ajay K. Nooka, Jonathan L. Kaufman, Cesar Rodriguez, Andrzej Jakubowiak, Yvonne Efebera, Brandi Reeves, Tanya Wildes, Sarah A. Holstein, Larry D. Anderson, Ashraf Badros, Leyla Shune, Ajai Chari, Huiling Pei, Annelore Cortoos, Sharmila Patel, J. Blake Bartlett, Jessica Vermeulen, Thomas S. Lin, Paul G. Richardson, Peter Voorhees

Published 2022-04-01

Get full text

Article

13

$Factors associated with refractoriness or early progression after idecabtagene vicleucel in patients with relapsed/ refractory multiple myeloma: US Myeloma Immunotherapy Consortium real world experience$